HBOT Conversations:
Dr. Hemal Mehta & Vibrant Health University
Dr. Hemal Mehta, MD is a Medical Director and an Independent Medical Examiner who focuses on pain management through a Regenerative medicine approach. Dr. Mehta is Board Certified in Physical Medicine and Pain Management. He received his Doctor of Medicine Degree from Ross University School of Medicine and completed his residency at East Carolina. He is the Medical Director of Vibrant Health of North Carolina, Tennessee Integrative Pain Institute, and TN Integrative Healthcare: Musculoskeletal and Regenerative Center; additionally, Dr. Mehta is the attending physician at Nashville Regenerative Orthopedics. Dr. Mehta is the 2013 recipient of the Inaugural Patient Appreciation Award at Nashville Academy of Medicine, and the 2004 Research Resident of the Year for East Carolina University. Dr. Mehta has extensive experience with stem cell proliferation, and angiogenesis. He has incorporated Ozone Injection Therapy, PRP (Platelet-Rich Plasma) Injections, Hyperbaric Oxygen Therapy and Regenerative Matrix and Regenerative Medicine Procedures – to name a few – into his integrative wellness & longevity medical practices.
Watch the Podcast
HBOT News Network welcomes back Dr. Hemal V. Mehta, M.D.; Medical Director of Vibrant Health of North Carolina. Dr. Mehta has joined HBOT News Network three times previously, where we focused heavily on the topics of fasting & regenerative medicine – see Dr. Mehta & Fasting, Dr. Mehta & Fasting (Part 2), and Dr. Mehta & Regenerative Medicine.
We are thrilled to have Dr. Mehta return to discuss Vibrant Health University. Vibrant Health University is a new start-up educational program through Vibrant Health. It is a way to help educate, not just the public, but also providers who are interested in performing regenerative therapies, regenerative injections, and providing an alternative to patients that’s not typically available.
Vibrant Health University wants to steer the medical field and general public away from the traditional heavy focus of pharmacology and surgical techniques; and educate people more on the integrative approaches available for regenerative therapies and regenerative treatments. What people can expect from Vibrant Health University (once it gets up and going), is a variety of online programs and podcasts they can watch. Then, if interested further, physicians can choose the option for an in-person educational program where Dr. Mehta or his team can visit the physician’s office (or the physician can visit them) and the physician can then witness live demonstrations, and learn how to do proper procedures for regenerative treatments, while incorporating their protocols into their treatment plans.
The courses at Vibrant Health University will be a structured program with a certification process. Dr. Mehta explains that they are planning to provide different tiers. For example, a lower tier, a medium tier, and a higher tier of education to providers based on their level of expertise, and based on how much knowledge they already have and how much they want to obtain. The ultimate goal of the program is to have the courses accredited by the appropriate certifying boards to count as continuing medical education for physicians.
Dr. Mehta & di Giralomo spend time discussing the importance of physician education, the continued benefits of fasting, and how to gain control of excessive inflammation.
Dr. Mehta remind us of Vibrant Health’s focus — to integrate traditional and non-traditional medicine to give each patient the best outlook and care. Ultimately, integrative medicine is integrating functional medicine and holistic therapies with what we’ve learned through history regarding how the human body works. God gave us everything we need to survive from the beginning of human life. Dr. Mehta ends this segment by explaining through the study of medicine, it’s incredibly difficult to not believe that there is a God or a higher power that has created this body. The human body is made to be able to tolerate all kinds of different injuries, in all kinds of different aspects of life, while adapting to the environment. There is absolutely no other machine that man has ever made that’s even similar to the divine healing capabilities of the human body.
If you’d like to know more about Vibrant Health University, please contact Vibrant Health at www.vibranthcs.com/contact/
Guest
Dr. Hemal Mehta
Subscribe Now, It’s Free!
Recent HBOT News
Clinical Trial – Intrathecal Neostigmine for Prevention of PDPH
Neuraxial blocks continue to be the cornerstone of anesthesia and postoperative analgesia for
normal vaginal delivery and elective caesarean section due to its approved safety and
efficiency for decades. Post-dural puncture headache (PDPH) is still one of the most common
complications of neuraxial anesthetic techniques. The headache could be severe and limit the
activities of the new mother to care for her baby, prolong hospital stay.
PDPH is defined as a headache that develops within five days of dural puncture and can’t be
attributed to any other types of headache and mostly is postural in character.
Neostigmine methylsulfate is a synthetic carbamic acid ester which reversibly inhibits the
enzyme Acetylcholine esterase (AChE) that makes more Acetylcholine molecules available at
cholinergic receptors. Neostigmine is used in anesthesia mainly as a reversal for
non-depolarizing neuromuscular agents.
Intrathecal (IT) neostigmine was tried as an adjuvant to local anesthetics in IT block for
elective cesarean sections to decrease local anesthetic consumption and to prolong
postoperative analgesia. Side effects of IT neostigmine are dose-dependent with doses more
than 25 µg especially nausea and vomiting and could be decreased by increasing the baricities
of the local anesthetic solutions and by early head up position after IT injection. However,
its effect on PDPH was not investigated before in literature.
Parturients will be randomly assigned into one of two groups: the intervention group will
receive 20 µg with IT Bupivacaine and the control group will receive an equivalent volume of
dextrose 5% with the IT Bupivacaine.
The objective of the current study is to evaluate the efficacy and safety of IT neostigmine
as an adjuvant to bupivacaine in reducing the incidence and severity of post-dural puncture
headache in parturients scheduled for an elective cesarean section.
Evidence brief: hyperbaric oxygen therapy (HBOT) for traumatic brain injury and/or post-traumatic stress disorder.
This report is a product of the VA Evidence-based Synthesis Program. The purpose is to provide “timely and accurate syntheses of targeted healthcare topics. to improve the health and healthcare of Veterans”. The authors have made a comprehensive search and analysis of the literature and make recommendations to assist clinicians in dealing with veterans suffering from either traumatic brain injury (TBI) or post-traumatic stress disorder (PTSD). The report is timely and of great potential impact given the vigorous and lengthy debate among hyperbaric physicians and lay people determined to find an answer for the large numbers of veterans deeply affected with some combination of PTSD and post-concussion dysfunction.
Clinical Trial – Hyperbaric Oxygen Therapy in Children With Inflammatory Bowel Diseases
The study assesses the effectiveness of hyperbaric oxygen therapy in the treatment of
inflammatory bowel disease in children.